Kiyohiro Ando
- Molecular Biology top 10%
- Epidemiology top 2%
- Immunology top 5%
- Hepatology top 1%
- Oncology top 5%
- Co-authors
- Francis V. ChisariLuca G. GuidottiRobert D. SchreiberAkira NakagawaraTetsuya IshikawaTakashi MoriyamaToshinori OzakiS Wirth
- Topics
- Neuroblastoma Research and Treatments (12 papers)Cancer-related Molecular Pathways (10 papers)Cell death mechanisms and regulation (8 papers)
- Cited by
- HepatologyImmunologyEpidemiology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Journal of Experimental Medicine
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Kiyohiro Ando
57 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.2k
- Epidemiology 1.1k
- Immunology 867
- Hepatology 725
- Oncology 664
Countries citing papers authored by Kiyohiro Ando
This map shows the geographic impact of Kiyohiro Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyohiro Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyohiro Ando more than expected).
Fields of papers citing papers by Kiyohiro Ando
This network shows the impact of papers produced by Kiyohiro Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyohiro Ando. The network helps show where Kiyohiro Ando may publish in the future.
Co-authorship network of co-authors of Kiyohiro Ando
This figure shows the co-authorship network connecting the top 25 collaborators of Kiyohiro Ando. A scholar is included among the top collaborators of Kiyohiro Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyohiro Ando. Kiyohiro Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 15 | |
| 5 | 11 | |
| 6 | 17 | |
| 7 | 9 | |
| 8 | 51 | |
| 9 | 9 | |
| 10 | 24 | |
| 11 | 22 | |
| 12 | 16 | |
| 13 | 47 | |
| 14 | 237 | |
| 15 | 17 | |
| 16 | 222 | |
| 17 | 26 | |
| 18 | Effectiveness of iodine in suppressing tumor cell proliferation in cultivated MCF-7 human breast cancer cells | 1 |
| 19 | 104 | |
| 20 | 384 |
About Kiyohiro Ando
Kiyohiro Ando is a scholar working on Neurology, Oncology and Cancer Research, having authored 59 papers that have together received 3.1k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (12 papers), Cancer-related Molecular Pathways (10 papers) and Cell death mechanisms and regulation (8 papers). The work is most often cited by research in Hepatology (725 citations), Immunology (867 citations) and Epidemiology (1.1k citations). Kiyohiro Ando has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Francis V. Chisari, Luca G. Guidotti, Robert D. Schreiber, Akira Nakagawara, Tetsuya Ishikawa, Takashi Moriyama, Toshinori Ozaki, S Wirth, H J Schlicht and S N Huang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.